Opinion: U.S. taxpayers should stop funding clinical trials of industry-owned drugs
STAT
FEBRUARY 4, 2025
I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008. At this stage, U.S.
Let's personalize your content